nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ALB—type 1 diabetes mellitus	0.379	1	CbGaD
Methotrexate—ATIC—pes—type 1 diabetes mellitus	0.0321	0.172	CbGeAlD
Methotrexate—FOLR1—nephron tubule—type 1 diabetes mellitus	0.00614	0.0328	CbGeAlD
Methotrexate—FOLR1—kidney—type 1 diabetes mellitus	0.0054	0.0289	CbGeAlD
Methotrexate—FOLR1—lymphoid tissue—type 1 diabetes mellitus	0.00464	0.0248	CbGeAlD
Methotrexate—FPGS—islet of Langerhans—type 1 diabetes mellitus	0.00446	0.0238	CbGeAlD
Methotrexate—GGH—nephron tubule—type 1 diabetes mellitus	0.00408	0.0218	CbGeAlD
Methotrexate—SLC19A1—lymphoid tissue—type 1 diabetes mellitus	0.00406	0.0217	CbGeAlD
Methotrexate—FPGS—retina—type 1 diabetes mellitus	0.00381	0.0204	CbGeAlD
Methotrexate—ATIC—retina—type 1 diabetes mellitus	0.00368	0.0197	CbGeAlD
Methotrexate—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00367	0.0342	CcSEcCtD
Methotrexate—SLCO4C1—nephron tubule—type 1 diabetes mellitus	0.00362	0.0194	CbGeAlD
Methotrexate—GGH—kidney—type 1 diabetes mellitus	0.00359	0.0192	CbGeAlD
Methotrexate—GGH—pancreas—type 1 diabetes mellitus	0.00356	0.0191	CbGeAlD
Methotrexate—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00342	0.0319	CcSEcCtD
Methotrexate—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00332	0.031	CcSEcCtD
Methotrexate—SLCO4C1—kidney—type 1 diabetes mellitus	0.00318	0.017	CbGeAlD
Methotrexate—SLC46A1—lymphoid tissue—type 1 diabetes mellitus	0.00313	0.0167	CbGeAlD
Methotrexate—ATIC—cardiovascular system—type 1 diabetes mellitus	0.00312	0.0167	CbGeAlD
Methotrexate—ATIC—kidney—type 1 diabetes mellitus	0.00305	0.0163	CbGeAlD
Methotrexate—ATIC—pancreas—type 1 diabetes mellitus	0.00303	0.0162	CbGeAlD
Methotrexate—SLC22A11—nephron tubule—type 1 diabetes mellitus	0.0028	0.015	CbGeAlD
Methotrexate—PGD—islet of Langerhans—type 1 diabetes mellitus	0.00278	0.0149	CbGeAlD
Methotrexate—FPGS—lymphoid tissue—type 1 diabetes mellitus	0.00271	0.0145	CbGeAlD
Methotrexate—SLCO3A1—retina—type 1 diabetes mellitus	0.00269	0.0144	CbGeAlD
Methotrexate—SLC22A6—nephron tubule—type 1 diabetes mellitus	0.00264	0.0141	CbGeAlD
Methotrexate—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00263	0.0245	CcSEcCtD
Methotrexate—ATIC—lymphoid tissue—type 1 diabetes mellitus	0.00262	0.014	CbGeAlD
Methotrexate—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00259	0.0241	CcSEcCtD
Methotrexate—SLCO1C1—kidney—type 1 diabetes mellitus	0.00254	0.0136	CbGeAlD
Methotrexate—Glossitis—Ramipril—type 1 diabetes mellitus	0.0025	0.0233	CcSEcCtD
Methotrexate—DHFR—retina—type 1 diabetes mellitus	0.00247	0.0132	CbGeAlD
Methotrexate—SLC22A11—kidney—type 1 diabetes mellitus	0.00246	0.0132	CbGeAlD
Methotrexate—AOX1—islet of Langerhans—type 1 diabetes mellitus	0.00245	0.0131	CbGeAlD
Methotrexate—SLC22A7—kidney—type 1 diabetes mellitus	0.0024	0.0129	CbGeAlD
Methotrexate—PGD—retina—type 1 diabetes mellitus	0.00238	0.0127	CbGeAlD
Methotrexate—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00236	0.022	CcSEcCtD
Methotrexate—TYMS—nephron tubule—type 1 diabetes mellitus	0.00235	0.0126	CbGeAlD
Methotrexate—DHFR—nephron tubule—type 1 diabetes mellitus	0.00233	0.0125	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—type 1 diabetes mellitus	0.00232	0.0124	CbGeAlD
Methotrexate—PGD—nephron tubule—type 1 diabetes mellitus	0.00224	0.012	CbGeAlD
Methotrexate—SLCO3A1—kidney—type 1 diabetes mellitus	0.00223	0.0119	CbGeAlD
Methotrexate—SLC16A1—retina—type 1 diabetes mellitus	0.00222	0.0119	CbGeAlD
Methotrexate—DHFR—cardiovascular system—type 1 diabetes mellitus	0.00209	0.0112	CbGeAlD
Methotrexate—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00209	0.0194	CcSEcCtD
Methotrexate—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00207	0.0192	CcSEcCtD
Methotrexate—DHFR—kidney—type 1 diabetes mellitus	0.00205	0.011	CbGeAlD
Methotrexate—PGD—cardiovascular system—type 1 diabetes mellitus	0.00201	0.0108	CbGeAlD
Methotrexate—AOX1—nephron tubule—type 1 diabetes mellitus	0.00197	0.0106	CbGeAlD
Methotrexate—PGD—kidney—type 1 diabetes mellitus	0.00197	0.0105	CbGeAlD
Methotrexate—MTHFR—lymphoid tissue—type 1 diabetes mellitus	0.00195	0.0104	CbGeAlD
Methotrexate—Polyuria—Ramipril—type 1 diabetes mellitus	0.00191	0.0178	CcSEcCtD
Methotrexate—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00191	0.0178	CcSEcCtD
Methotrexate—SLC16A1—cardiovascular system—type 1 diabetes mellitus	0.00188	0.01	CbGeAlD
Methotrexate—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00186	0.0174	CcSEcCtD
Methotrexate—SLC16A1—kidney—type 1 diabetes mellitus	0.00184	0.00983	CbGeAlD
Methotrexate—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00181	0.0169	CcSEcCtD
Methotrexate—SLCO1B1—kidney—type 1 diabetes mellitus	0.00179	0.00956	CbGeAlD
Methotrexate—TYMS—lymphoid tissue—type 1 diabetes mellitus	0.00178	0.0095	CbGeAlD
Methotrexate—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00178	0.0165	CcSEcCtD
Methotrexate—DHFR—lymphoid tissue—type 1 diabetes mellitus	0.00176	0.00941	CbGeAlD
Methotrexate—AOX1—kidney—type 1 diabetes mellitus	0.00173	0.00928	CbGeAlD
Methotrexate—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00173	0.0161	CcSEcCtD
Methotrexate—AOX1—pancreas—type 1 diabetes mellitus	0.00172	0.00922	CbGeAlD
Methotrexate—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00171	0.0159	CcSEcCtD
Methotrexate—ABCC3—kidney—type 1 diabetes mellitus	0.0017	0.00907	CbGeAlD
Methotrexate—PGD—lymphoid tissue—type 1 diabetes mellitus	0.00169	0.00904	CbGeAlD
Methotrexate—ABCC10—kidney—type 1 diabetes mellitus	0.00169	0.00903	CbGeAlD
Methotrexate—ABCC4—nephron tubule—type 1 diabetes mellitus	0.00159	0.00852	CbGeAlD
Methotrexate—SLC22A8—nephron tubule—type 1 diabetes mellitus	0.00158	0.00846	CbGeAlD
Methotrexate—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00155	0.0144	CcSEcCtD
Methotrexate—ABCC2—nephron tubule—type 1 diabetes mellitus	0.00154	0.00825	CbGeAlD
Methotrexate—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00151	0.0141	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00151	0.0141	CcSEcCtD
Methotrexate—SLCO1A2—kidney—type 1 diabetes mellitus	0.00146	0.00778	CbGeAlD
Methotrexate—ABCC10—lymphoid tissue—type 1 diabetes mellitus	0.00145	0.00776	CbGeAlD
Methotrexate—Asthma—Ramipril—type 1 diabetes mellitus	0.00145	0.0135	CcSEcCtD
Methotrexate—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00143	0.0134	CcSEcCtD
Methotrexate—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00142	0.0132	CcSEcCtD
Methotrexate—ABCC4—kidney—type 1 diabetes mellitus	0.0014	0.00749	CbGeAlD
Methotrexate—ABCC4—pancreas—type 1 diabetes mellitus	0.00139	0.00744	CbGeAlD
Methotrexate—SLC22A8—kidney—type 1 diabetes mellitus	0.00139	0.00743	CbGeAlD
Methotrexate—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00139	0.0129	CcSEcCtD
Methotrexate—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00138	0.0128	CcSEcCtD
Methotrexate—ABCC2—kidney—type 1 diabetes mellitus	0.00136	0.00725	CbGeAlD
Methotrexate—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00135	0.0126	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00135	0.0125	CcSEcCtD
Methotrexate—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00133	0.0124	CcSEcCtD
Methotrexate—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00132	0.0123	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00128	0.0119	CcSEcCtD
Methotrexate—Renal failure—Ramipril—type 1 diabetes mellitus	0.00127	0.0118	CcSEcCtD
Methotrexate—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00126	0.0117	CcSEcCtD
Methotrexate—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00126	0.0117	CcSEcCtD
Methotrexate—Sweating—Ramipril—type 1 diabetes mellitus	0.00124	0.0115	CcSEcCtD
Methotrexate—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00122	0.0114	CcSEcCtD
Methotrexate—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00122	0.0113	CcSEcCtD
Methotrexate—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.0012	0.0112	CcSEcCtD
Methotrexate—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00116	0.0108	CcSEcCtD
Methotrexate—ABCG2—nephron tubule—type 1 diabetes mellitus	0.00112	0.00602	CbGeAlD
Methotrexate—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00112	0.0104	CcSEcCtD
Methotrexate—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0011	0.0102	CcSEcCtD
Methotrexate—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00108	0.0101	CcSEcCtD
Methotrexate—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00105	0.00976	CcSEcCtD
Methotrexate—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00104	0.00973	CcSEcCtD
Methotrexate—Alopecia—Ramipril—type 1 diabetes mellitus	0.00102	0.00954	CcSEcCtD
Methotrexate—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00102	0.00946	CcSEcCtD
Methotrexate—Erythema—Ramipril—type 1 diabetes mellitus	0.00101	0.0094	CcSEcCtD
Methotrexate—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00101	0.0094	CcSEcCtD
Methotrexate—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000988	0.00921	CcSEcCtD
Methotrexate—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000936	0.00872	CcSEcCtD
Methotrexate—Malaise—Ramipril—type 1 diabetes mellitus	0.00091	0.00848	CcSEcCtD
Methotrexate—Vertigo—Ramipril—type 1 diabetes mellitus	0.000907	0.00845	CcSEcCtD
Methotrexate—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000903	0.00842	CcSEcCtD
Methotrexate—Cough—Ramipril—type 1 diabetes mellitus	0.00088	0.0082	CcSEcCtD
Methotrexate—Convulsion—Ramipril—type 1 diabetes mellitus	0.000874	0.00815	CcSEcCtD
Methotrexate—Chest pain—Ramipril—type 1 diabetes mellitus	0.000859	0.008	CcSEcCtD
Methotrexate—Myalgia—Ramipril—type 1 diabetes mellitus	0.000859	0.008	CcSEcCtD
Methotrexate—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000859	0.008	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000853	0.00795	CcSEcCtD
Methotrexate—Discomfort—Ramipril—type 1 diabetes mellitus	0.000849	0.00791	CcSEcCtD
Methotrexate—Confusional state—Ramipril—type 1 diabetes mellitus	0.00083	0.00774	CcSEcCtD
Methotrexate—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000823	0.00767	CcSEcCtD
Methotrexate—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000808	0.00753	CcSEcCtD
Methotrexate—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000806	0.00751	CcSEcCtD
Methotrexate—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0008	0.00745	CcSEcCtD
Methotrexate—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000796	0.00742	CcSEcCtD
Methotrexate—Anorexia—Ramipril—type 1 diabetes mellitus	0.000785	0.00731	CcSEcCtD
Methotrexate—Hypotension—Ramipril—type 1 diabetes mellitus	0.000769	0.00717	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00075	0.00699	CcSEcCtD
Methotrexate—Insomnia—Ramipril—type 1 diabetes mellitus	0.000745	0.00694	CcSEcCtD
Methotrexate—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000739	0.00689	CcSEcCtD
Methotrexate—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000734	0.00684	CcSEcCtD
Methotrexate—Somnolence—Ramipril—type 1 diabetes mellitus	0.000732	0.00682	CcSEcCtD
Methotrexate—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000725	0.00675	CcSEcCtD
Methotrexate—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000716	0.00667	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000711	0.00662	CcSEcCtD
Methotrexate—Fatigue—Ramipril—type 1 diabetes mellitus	0.00071	0.00662	CcSEcCtD
Methotrexate—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000689	0.00368	CbGeAlD
Methotrexate—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000679	0.00632	CcSEcCtD
Methotrexate—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000673	0.00627	CcSEcCtD
Methotrexate—Urticaria—Ramipril—type 1 diabetes mellitus	0.000654	0.0061	CcSEcCtD
Methotrexate—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000651	0.00607	CcSEcCtD
Methotrexate—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000651	0.00607	CcSEcCtD
Methotrexate—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000607	0.00565	CcSEcCtD
Methotrexate—Asthenia—Ramipril—type 1 diabetes mellitus	0.000591	0.00551	CcSEcCtD
Methotrexate—ABCB1—retina—type 1 diabetes mellitus	0.000589	0.00315	CbGeAlD
Methotrexate—Pruritus—Ramipril—type 1 diabetes mellitus	0.000583	0.00543	CcSEcCtD
Methotrexate—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000563	0.00525	CcSEcCtD
Methotrexate—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000555	0.00297	CbGeAlD
Methotrexate—Dizziness—Ramipril—type 1 diabetes mellitus	0.000545	0.00507	CcSEcCtD
Methotrexate—Vomiting—Ramipril—type 1 diabetes mellitus	0.000524	0.00488	CcSEcCtD
Methotrexate—Rash—Ramipril—type 1 diabetes mellitus	0.000519	0.00484	CcSEcCtD
Methotrexate—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000519	0.00483	CcSEcCtD
Methotrexate—Headache—Ramipril—type 1 diabetes mellitus	0.000516	0.00481	CcSEcCtD
Methotrexate—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000498	0.00266	CbGeAlD
Methotrexate—Nausea—Ramipril—type 1 diabetes mellitus	0.000489	0.00456	CcSEcCtD
Methotrexate—ABCB1—kidney—type 1 diabetes mellitus	0.000487	0.00261	CbGeAlD
Methotrexate—ABCB1—pancreas—type 1 diabetes mellitus	0.000484	0.00259	CbGeAlD
Methotrexate—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000419	0.00224	CbGeAlD
Methotrexate—SLC16A1—Hemostasis—NOS3—type 1 diabetes mellitus	6.04e-05	0.000185	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—type 1 diabetes mellitus	6.04e-05	0.000185	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCC8—type 1 diabetes mellitus	6.01e-05	0.000184	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GCG—type 1 diabetes mellitus	6e-05	0.000184	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—type 1 diabetes mellitus	5.99e-05	0.000183	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD86—type 1 diabetes mellitus	5.98e-05	0.000183	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTT1—type 1 diabetes mellitus	5.98e-05	0.000183	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ITPR3—type 1 diabetes mellitus	5.97e-05	0.000183	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	5.87e-05	0.00018	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—EGFR—type 1 diabetes mellitus	5.86e-05	0.000179	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD86—type 1 diabetes mellitus	5.84e-05	0.000179	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—INS—type 1 diabetes mellitus	5.72e-05	0.000175	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	5.72e-05	0.000175	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITPR3—type 1 diabetes mellitus	5.65e-05	0.000173	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—HBA1—type 1 diabetes mellitus	5.62e-05	0.000172	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	5.61e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—type 1 diabetes mellitus	5.6e-05	0.000172	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOC3—type 1 diabetes mellitus	5.58e-05	0.000171	CbGpPWpGaD
Methotrexate—PGD—Disease—TYK2—type 1 diabetes mellitus	5.58e-05	0.000171	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.58e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCC8—type 1 diabetes mellitus	5.57e-05	0.00017	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	5.56e-05	0.00017	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—type 1 diabetes mellitus	5.52e-05	0.000169	CbGpPWpGaD
Methotrexate—FPGS—Disease—STAT3—type 1 diabetes mellitus	5.49e-05	0.000168	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTT1—type 1 diabetes mellitus	5.48e-05	0.000168	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—type 1 diabetes mellitus	5.48e-05	0.000168	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.47e-05	0.000167	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GCG—type 1 diabetes mellitus	5.46e-05	0.000167	CbGpPWpGaD
Methotrexate—MTHFR—Disease—ERBB3—type 1 diabetes mellitus	5.39e-05	0.000165	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ITPR3—type 1 diabetes mellitus	5.39e-05	0.000165	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SH2B3—type 1 diabetes mellitus	5.32e-05	0.000163	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD86—type 1 diabetes mellitus	5.31e-05	0.000163	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CCR5—type 1 diabetes mellitus	5.3e-05	0.000162	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC11A1—type 1 diabetes mellitus	5.28e-05	0.000162	CbGpPWpGaD
Methotrexate—AOX1—Disease—ERBB3—type 1 diabetes mellitus	5.27e-05	0.000161	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—type 1 diabetes mellitus	5.25e-05	0.000161	CbGpPWpGaD
Methotrexate—PGD—Metabolism—INS—type 1 diabetes mellitus	5.23e-05	0.00016	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CAT—type 1 diabetes mellitus	5.2e-05	0.000159	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—type 1 diabetes mellitus	5.18e-05	0.000159	CbGpPWpGaD
Methotrexate—AOX1—Disease—CCR5—type 1 diabetes mellitus	5.18e-05	0.000159	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HLA-A—type 1 diabetes mellitus	5.17e-05	0.000158	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.17e-05	0.000158	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.12e-05	0.000157	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—type 1 diabetes mellitus	5.12e-05	0.000157	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	5.1e-05	0.000156	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CAT—type 1 diabetes mellitus	5.08e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HBA1—type 1 diabetes mellitus	5.07e-05	0.000155	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.06e-05	0.000155	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.05e-05	0.000155	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—type 1 diabetes mellitus	5.05e-05	0.000155	CbGpPWpGaD
Methotrexate—AOX1—Disease—HLA-A—type 1 diabetes mellitus	5.05e-05	0.000155	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ITPR3—type 1 diabetes mellitus	5.04e-05	0.000154	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOC3—type 1 diabetes mellitus	5.04e-05	0.000154	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—type 1 diabetes mellitus	5.02e-05	0.000154	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—KCNJ11—type 1 diabetes mellitus	5e-05	0.000153	CbGpPWpGaD
Methotrexate—FPGS—Disease—EGFR—type 1 diabetes mellitus	4.99e-05	0.000153	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	4.98e-05	0.000153	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GCG—type 1 diabetes mellitus	4.97e-05	0.000152	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IGF1—type 1 diabetes mellitus	4.97e-05	0.000152	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTT1—type 1 diabetes mellitus	4.95e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	4.92e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	4.87e-05	0.000149	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.81e-05	0.000147	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.81e-05	0.000147	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—type 1 diabetes mellitus	4.8e-05	0.000147	CbGpPWpGaD
Methotrexate—DHFR—Disease—ERBB3—type 1 diabetes mellitus	4.79e-05	0.000147	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GCG—type 1 diabetes mellitus	4.76e-05	0.000146	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—KCNJ11—type 1 diabetes mellitus	4.75e-05	0.000145	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IAPP—type 1 diabetes mellitus	4.71e-05	0.000144	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOC3—type 1 diabetes mellitus	4.71e-05	0.000144	CbGpPWpGaD
Methotrexate—DHFR—Disease—CCR5—type 1 diabetes mellitus	4.71e-05	0.000144	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—type 1 diabetes mellitus	4.71e-05	0.000144	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ITPR3—type 1 diabetes mellitus	4.69e-05	0.000144	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CAT—type 1 diabetes mellitus	4.62e-05	0.000141	CbGpPWpGaD
Methotrexate—DHFR—Disease—HLA-A—type 1 diabetes mellitus	4.59e-05	0.000141	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—type 1 diabetes mellitus	4.59e-05	0.00014	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.56e-05	0.00014	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	4.53e-05	0.000139	CbGpPWpGaD
Methotrexate—ABCC1—Disease—B2M—type 1 diabetes mellitus	4.53e-05	0.000139	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—type 1 diabetes mellitus	4.51e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—type 1 diabetes mellitus	4.51e-05	0.000138	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—type 1 diabetes mellitus	4.5e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	4.49e-05	0.000137	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HBA1—type 1 diabetes mellitus	4.41e-05	0.000135	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—KCNJ11—type 1 diabetes mellitus	4.4e-05	0.000135	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—type 1 diabetes mellitus	4.39e-05	0.000134	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOC3—type 1 diabetes mellitus	4.39e-05	0.000134	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GCG—type 1 diabetes mellitus	4.37e-05	0.000134	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	4.36e-05	0.000134	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD80—type 1 diabetes mellitus	4.36e-05	0.000134	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.34e-05	0.000133	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTT1—type 1 diabetes mellitus	4.31e-05	0.000132	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	4.3e-05	0.000132	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—STAT3—type 1 diabetes mellitus	4.27e-05	0.000131	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD80—type 1 diabetes mellitus	4.26e-05	0.00013	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	4.25e-05	0.00013	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.25e-05	0.00013	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ITPR3—type 1 diabetes mellitus	4.22e-05	0.000129	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HBA2—type 1 diabetes mellitus	4.21e-05	0.000129	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CAT—type 1 diabetes mellitus	4.21e-05	0.000129	CbGpPWpGaD
Methotrexate—MTHFR—Disease—INS—type 1 diabetes mellitus	4.12e-05	0.000126	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	4.12e-05	0.000126	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	4.08e-05	0.000125	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CAT—type 1 diabetes mellitus	4.03e-05	0.000123	CbGpPWpGaD
Methotrexate—AOX1—Disease—INS—type 1 diabetes mellitus	4.03e-05	0.000123	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ITPR3—type 1 diabetes mellitus	4.01e-05	0.000123	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—type 1 diabetes mellitus	4e-05	0.000122	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	3.98e-05	0.000122	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HBA1—type 1 diabetes mellitus	3.97e-05	0.000122	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.97e-05	0.000122	CbGpPWpGaD
Methotrexate—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	3.96e-05	0.000121	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOC3—type 1 diabetes mellitus	3.95e-05	0.000121	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GCG—type 1 diabetes mellitus	3.94e-05	0.000121	CbGpPWpGaD
Methotrexate—PGD—Disease—STAT3—type 1 diabetes mellitus	3.91e-05	0.00012	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EGFR—type 1 diabetes mellitus	3.88e-05	0.000119	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTT1—type 1 diabetes mellitus	3.88e-05	0.000119	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD80—type 1 diabetes mellitus	3.88e-05	0.000119	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	3.87e-05	0.000118	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—type 1 diabetes mellitus	3.83e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—type 1 diabetes mellitus	3.82e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS1—type 1 diabetes mellitus	3.79e-05	0.000116	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.78e-05	0.000116	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HBA1—type 1 diabetes mellitus	3.78e-05	0.000116	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOC3—type 1 diabetes mellitus	3.75e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	3.71e-05	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CAT—type 1 diabetes mellitus	3.7e-05	0.000113	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	3.69e-05	0.000113	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTT1—type 1 diabetes mellitus	3.68e-05	0.000113	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TYK2—type 1 diabetes mellitus	3.68e-05	0.000113	CbGpPWpGaD
Methotrexate—DHFR—Disease—INS—type 1 diabetes mellitus	3.66e-05	0.000112	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—type 1 diabetes mellitus	3.61e-05	0.000111	CbGpPWpGaD
Methotrexate—AOX1—Disease—TYK2—type 1 diabetes mellitus	3.6e-05	0.00011	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.57e-05	0.000109	CbGpPWpGaD
Methotrexate—PGD—Disease—EGFR—type 1 diabetes mellitus	3.55e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PRKCQ—type 1 diabetes mellitus	3.55e-05	0.000109	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.55e-05	0.000109	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—type 1 diabetes mellitus	3.53e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	3.5e-05	0.000107	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	3.5e-05	0.000107	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	3.47e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	3.47e-05	0.000106	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—INS—type 1 diabetes mellitus	3.45e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCC1—Disease—VAV1—type 1 diabetes mellitus	3.45e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.44e-05	0.000105	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	3.44e-05	0.000105	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GCG—type 1 diabetes mellitus	3.43e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	3.41e-05	0.000104	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.4e-05	0.000104	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.4e-05	0.000104	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—INS—type 1 diabetes mellitus	3.37e-05	0.000103	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	3.35e-05	0.000103	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAT—type 1 diabetes mellitus	3.34e-05	0.000102	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—type 1 diabetes mellitus	3.33e-05	0.000102	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.31e-05	0.000101	CbGpPWpGaD
Methotrexate—DHFR—Disease—TYK2—type 1 diabetes mellitus	3.27e-05	0.0001	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—type 1 diabetes mellitus	3.25e-05	9.96e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.23e-05	9.89e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—type 1 diabetes mellitus	3.21e-05	9.83e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—type 1 diabetes mellitus	3.16e-05	9.69e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—type 1 diabetes mellitus	3.09e-05	9.46e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GCG—type 1 diabetes mellitus	3.09e-05	9.46e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INS—type 1 diabetes mellitus	3.07e-05	9.39e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—type 1 diabetes mellitus	3.03e-05	9.27e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.01e-05	9.21e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD86—type 1 diabetes mellitus	3.01e-05	9.21e-05	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.99e-05	9.15e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—type 1 diabetes mellitus	2.99e-05	9.14e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—type 1 diabetes mellitus	2.96e-05	9.06e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—type 1 diabetes mellitus	2.96e-05	9.05e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	2.95e-05	9.03e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GCG—type 1 diabetes mellitus	2.94e-05	8.99e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAT—type 1 diabetes mellitus	2.91e-05	8.9e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—type 1 diabetes mellitus	2.81e-05	8.61e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INS—type 1 diabetes mellitus	2.79e-05	8.55e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—type 1 diabetes mellitus	2.73e-05	8.36e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	2.72e-05	8.32e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	2.72e-05	8.31e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ERBB3—type 1 diabetes mellitus	2.71e-05	8.3e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—type 1 diabetes mellitus	2.69e-05	8.24e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INS—type 1 diabetes mellitus	2.68e-05	8.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—type 1 diabetes mellitus	2.67e-05	8.16e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAT—type 1 diabetes mellitus	2.62e-05	8.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HLA-A—type 1 diabetes mellitus	2.6e-05	7.96e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—STAT3—type 1 diabetes mellitus	2.58e-05	7.89e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—type 1 diabetes mellitus	2.56e-05	7.84e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	2.54e-05	7.76e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.53e-05	7.73e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—STAT3—type 1 diabetes mellitus	2.52e-05	7.71e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAT—type 1 diabetes mellitus	2.49e-05	7.61e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INS—type 1 diabetes mellitus	2.46e-05	7.52e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—type 1 diabetes mellitus	2.45e-05	7.51e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—type 1 diabetes mellitus	2.45e-05	7.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.4e-05	7.36e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.38e-05	7.28e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—type 1 diabetes mellitus	2.35e-05	7.19e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EGFR—type 1 diabetes mellitus	2.34e-05	7.17e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	2.3e-05	7.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	2.29e-05	7.02e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—STAT3—type 1 diabetes mellitus	2.29e-05	7.01e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—EGFR—type 1 diabetes mellitus	2.29e-05	7.01e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—type 1 diabetes mellitus	2.26e-05	6.92e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—type 1 diabetes mellitus	2.25e-05	6.89e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	2.25e-05	6.88e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INS—type 1 diabetes mellitus	2.22e-05	6.78e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD80—type 1 diabetes mellitus	2.19e-05	6.72e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.16e-05	6.6e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—type 1 diabetes mellitus	2.15e-05	6.59e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.14e-05	6.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	2.11e-05	6.45e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—EGFR—type 1 diabetes mellitus	2.08e-05	6.38e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—type 1 diabetes mellitus	2.07e-05	6.35e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	2.04e-05	6.24e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—type 1 diabetes mellitus	2.03e-05	6.22e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.01e-05	6.15e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—type 1 diabetes mellitus	1.94e-05	5.95e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—type 1 diabetes mellitus	1.93e-05	5.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.89e-05	5.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.88e-05	5.75e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TYK2—type 1 diabetes mellitus	1.85e-05	5.67e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.84e-05	5.65e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—type 1 diabetes mellitus	1.82e-05	5.57e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—type 1 diabetes mellitus	1.8e-05	5.51e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—type 1 diabetes mellitus	1.77e-05	5.41e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—type 1 diabetes mellitus	1.76e-05	5.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—type 1 diabetes mellitus	1.74e-05	5.31e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—type 1 diabetes mellitus	1.73e-05	5.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.69e-05	5.18e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCG—type 1 diabetes mellitus	1.68e-05	5.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—type 1 diabetes mellitus	1.67e-05	5.13e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	1.65e-05	5.05e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.62e-05	4.95e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—type 1 diabetes mellitus	1.6e-05	4.9e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—type 1 diabetes mellitus	1.59e-05	4.87e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—type 1 diabetes mellitus	1.53e-05	4.68e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—type 1 diabetes mellitus	1.52e-05	4.66e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	1.51e-05	4.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.47e-05	4.5e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	1.45e-05	4.43e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.42e-05	4.35e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	1.4e-05	4.29e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	1.34e-05	4.1e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STAT3—type 1 diabetes mellitus	1.3e-05	3.97e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.24e-05	3.81e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EGFR—type 1 diabetes mellitus	1.18e-05	3.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—type 1 diabetes mellitus	9.43e-06	2.89e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—type 1 diabetes mellitus	9.06e-06	2.77e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—type 1 diabetes mellitus	8.27e-06	2.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—type 1 diabetes mellitus	8.26e-06	2.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	7.57e-06	2.32e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	7.24e-06	2.22e-05	CbGpPWpGaD
